• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Lab Anal . Severe Coronavirus disease 2019 pneumonia patients showed signs of aggravated renal impairment

tetano

Editor, Senior Moderator
J Clin Lab Anal


. 2020 Aug 25;e23535.
doi: 10.1002/jcla.23535. Online ahead of print.
Severe Coronavirus disease 2019 pneumonia patients showed signs of aggravated renal impairment


Menglu Gao[SUP] 1 [/SUP], Qianying Wang[SUP] 1 [/SUP], Jianhao Wei[SUP] 1 [/SUP], Zhaoqin Zhu[SUP] 1 [/SUP], Haicong Li[SUP] 1 [/SUP]



Affiliations

Abstract

Background: This objective of this study was to identify a sensitive indicator of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Methods: Samples were collected from 136 patients with Coronavirus disease 2019 (COVID-19) pneumonia admitted to the Shanghai public health clinical center (116 mild, 20 severe). The concentrations of serum urea, Uric Acid (UA), Creatinine (CREA), Erythrocyte sedimentation rate (ESR), high-sensitivity C-reactive protein (hs-CRP), procalcitonin (PCT), and urine protein (Pro) have been tested in this study.
Results: Higher levels of urea (female 7.00 ? 3.31, male 8.87 ? 5.18) Pro (female7/7, male 12/13), hs-CRP (female 2/7, male 5/13) ESR (female 94.43 ? 33.26, male 67.85 ? 22.77) were found in severe patients compared with the mild (urea: female 3.71 ? 1.00, male 4.42 ? 1.14; Pro: female 3/46, male 12/70; hs-CRP: female 1/46, male 3/70; ESR: female 43.32 ? 33.24, male 21.64 ? 21.82). UA is lower in the severe group (female 146.90 ? 54.01, male 139.34 ? 66.95) than in mild group (female 251.99 ? 64.35, male 339.81 ? 71.32). CREA and PCT did not show a significant difference between mild and severe patients, but the difference among the five biological markers (urea, Pro, hs-CRP, ESR, and UA) between mild and severe patients we tested was small (P < .05).
Conclusion: Severe COVID-19 patients had higher levels of urea and Pro, while their UA levels were lower, reflecting poor kidney function in severe patients. However, higher levels of hs-CRP, ESR indicated that inflammatory responses were more active in severe patients.

Keywords: COVID-19; ESR; UA; creatinine; hs-CRP; procalcitonin; urea; urine protein.
 
Back
Top Bottom